Clarysse H J
Acta Psychiatr Belg. 1978 Jan-Feb;78(1):129-33.
An ambulatory population of 18 men and 4 women, aged 17 to 61 years (mean 30.3), were treated with bromperidol oral drops for an eight-week study period.
investigation of tolerability, side effects and psychopharmacological effects; determination of the optimal dose. The Wirtschafts Mathematik AG Zurich case report form was used. Various medical, neurological and psychic parameters were recorded before the study and after the first, second, fourth, sixth and eighth weeks of treatment. Bromperidol is a potent and safe neuroleptic agent of polyvalent action, which can be administered in one single daily dose and is very well tolerated in ambulatory conditions, without antiparkinsonians in the doses used.
18名男性和4名女性组成的非卧床人群，年龄在17至61岁之间（平均30.3岁），在为期八周的研究期间接受了溴哌利多口服液治疗。
调查耐受性、副作用和精神药理学作用；确定最佳剂量。使用了苏黎世经济数学股份公司的病例报告表。在研究前以及治疗的第一、第二、第四、第六和第八周后记录了各种医学、神经学和精神学参数。溴哌利多是一种强效且安全的具有多价作用的抗精神病药物，可每日单次给药，在非卧床情况下耐受性良好，所用剂量无需合用抗帕金森病药物。
